<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24976">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01801514</url>
  </required_header>
  <id_info>
    <org_study_id>iCT DL</org_study_id>
    <nct_id>NCT01801514</nct_id>
  </id_info>
  <brief_title>Applications of Dual-Energy Computed Tomography</brief_title>
  <official_title>Applications of Dual-Energy Computed Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Healthcare</source>
  <oversight_info>
    <authority>Israel: Israeli Health Ministry Pharmaceutical Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the feasibility of multilayer detection-based dual
      energy computed tomography scanner and to assess the added diagnostic value of dual energy
      applications
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Capability of producing dual energy computed tomography imaging and dual energy applications</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Other Conditions That May Be A Focus of Clinical Attention</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Computed Tomography scan</intervention_name>
    <description>Routine Computed Tomography scan</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female subject

          2. Subjects with relative clinical findings indicative for CT examination. CT referral
             request approved by a physician is needed

          3. Voluntary signed the Informed Consent Form

        Exclusion Criteria:

          1. Pregnant or potentially pregnant female subjects

          2. Subjects who are not able or not willing to give written Informed Consent without a
             caregiver consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob Sosna, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Zimam A Romman, M.Sc.</last_name>
    <phone>+972547299677</phone>
    <email>Zimam.Romman@Philips.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah-Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zimam A Romman, M.Sc.</last_name>
      <phone>+972-547299677</phone>
      <email>zimam.romman@philips.com</email>
    </contact>
    <investigator>
      <last_name>Jacob Sosna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 27, 2013</lastchanged_date>
  <firstreceived_date>February 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
